Search research articles
Contact Us
Filters
Showing results (51-60 of 64) with videos related to
Page
of 7
Sort By:
Neurology
|
September 21, 2018
Smartphone motor testing to distinguish idiopathic REM sleep behavior disorder, controls, and PD
Siddharth Arora, Fahd Baig, Christine Lo, et al.
The Journal of Biological Chemistry
|
March 5, 2021
CowN sustains nitrogenase turnover in the presence of the inhibitor carbon monoxide
Michael S Medina, Kevin O Bretzing, Richard A Aviles, et al.
NPJ Digital Medicine
|
December 1, 2025
Smartphone-based prediction of dopaminergic deficit in prodromal and manifest Parkinson's disease
Katarina M Gunter, Karolien Groenewald, Timothee Aubourg, et al.
Clinical and Translational Science
|
December 26, 2025
Lexicon for Clonal Hematopoiesis in Liquid Biopsy
Robert Tell, Ahmet Zehir, Andrew T Anfora, et al.
Progress in Neurobiology
|
February 15, 2020
Deep phenotyping of peripheral tissue facilitates mechanistic disease stratification in sporadic Parkinson's disease
Phillippa J Carling, Heather Mortiboys, Claire Green, et al.
BMJ Neurology Open
|
July 6, 2026
Identifying and predicting fast versus slow Parkinson's disease motor progressors using clinical and digital data
Timothee Aubourg, Katarina M Gunter, Christine Lo, et al.
Oncology and Therapy
|
July 22, 2024
Dynamic Changes in Circulating Tumor Fraction as a Predictor of Real-World Clinical Outcomes in Solid Tumor Malignancy Patients Treated with Immunotherapy
Ryan D Gentzler, John Guittar, Akash Mitra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2026
Circulating tumor DNA dynamics in patients with liver-limited metastatic colorectal cancer resected after first-line systemic treatment
Roberto Moretto, Vittorio Studiale, Seung Won Hyun, et al.
BMJ Open
|
May 29, 2021
Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson's disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The 'Exenatide-PD3' study
Nirosen Vijiaratnam, Christine Girges, Grace Auld, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 8, 2024
A Tumor-Naïve ctDNA Assay Detects Minimal Residual Disease in Resected Stage II or III Colorectal Cancer and Predicts Recurrence: Subset Analysis from the GALAXY Study in CIRCULATE-Japan
Yoshiaki Nakamura, Kristiyana Kaneva, Christine Lo, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 64) with videos related to
Sort By:
Page
of 7
Neurology
|
September 21, 2018
Smartphone motor testing to distinguish idiopathic REM sleep behavior disorder, controls, and PD
Siddharth Arora, Fahd Baig, Christine Lo, et al.
The Journal of Biological Chemistry
|
March 5, 2021
CowN sustains nitrogenase turnover in the presence of the inhibitor carbon monoxide
Michael S Medina, Kevin O Bretzing, Richard A Aviles, et al.
NPJ Digital Medicine
|
December 1, 2025
Smartphone-based prediction of dopaminergic deficit in prodromal and manifest Parkinson's disease
Katarina M Gunter, Karolien Groenewald, Timothee Aubourg, et al.
Clinical and Translational Science
|
December 26, 2025
Lexicon for Clonal Hematopoiesis in Liquid Biopsy
Robert Tell, Ahmet Zehir, Andrew T Anfora, et al.
Progress in Neurobiology
|
February 15, 2020
Deep phenotyping of peripheral tissue facilitates mechanistic disease stratification in sporadic Parkinson's disease
Phillippa J Carling, Heather Mortiboys, Claire Green, et al.
BMJ Neurology Open
|
July 6, 2026
Identifying and predicting fast versus slow Parkinson's disease motor progressors using clinical and digital data
Timothee Aubourg, Katarina M Gunter, Christine Lo, et al.
Oncology and Therapy
|
July 22, 2024
Dynamic Changes in Circulating Tumor Fraction as a Predictor of Real-World Clinical Outcomes in Solid Tumor Malignancy Patients Treated with Immunotherapy
Ryan D Gentzler, John Guittar, Akash Mitra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2026
Circulating tumor DNA dynamics in patients with liver-limited metastatic colorectal cancer resected after first-line systemic treatment
Roberto Moretto, Vittorio Studiale, Seung Won Hyun, et al.
BMJ Open
|
May 29, 2021
Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson's disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The 'Exenatide-PD3' study
Nirosen Vijiaratnam, Christine Girges, Grace Auld, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 8, 2024
A Tumor-Naïve ctDNA Assay Detects Minimal Residual Disease in Resected Stage II or III Colorectal Cancer and Predicts Recurrence: Subset Analysis from the GALAXY Study in CIRCULATE-Japan
Yoshiaki Nakamura, Kristiyana Kaneva, Christine Lo, et al.
Page
of 7